Vontobel Holding Ltd. Bluebird Bio, Inc. Transaction History

Vontobel Holding Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$3.75 - $7.39 $57,060 - $112,446	15,216 New	15,216 $96,000
Q2 2021 Aug 06, 2021	SELL	$18.04 - $22.09 $541,308 - $662,832	-30,006 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$16.59 - $33.89 $1,410 - $2,880	-85 Reduced 0.28%	30,006 $905,000
Q4 2020 Feb 12, 2021	BUY	$27.5 - $37.92 $827,502 - $1.14 Million	30,091 New	30,091 $1.3 Million

27M

191K

299K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $561M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.